Navigation Links
Dealing heart disease risk in ethnic minorities

According to a latest study researchers have observed that doctors should use lower thresholds when treating high blood pressure and other cardiac risk factors in ethnic minorities.// Researchers at St George's Hospital, Georgia have carried out a population survey involving 1250 men and women of various ethnic origins, looking at their heart disease and stroke risk factors. They find that people of African origin have the lowest risk of heart disease, and the highest risk of stroke.

Meanwhile, south Asians have the highest risk of heart disease and stroke combined. Also, the ethnic minorities have the highest levels of hypertension in the population. While many were being treated, there were also many instances where target blood pressure was not being met. This suggests that African and South Asian people are at risk of hypertension which is not properly controlled - and this contributes to higher levels of heart disease and stroke. So doctors should maybe take a lower threshold blood pressure in ethnic minorities before beginning treatment.


'"/>




Page: 1

Related medicine news :

1. Dealing with personality disorders
2. Dealing With Stress Results In Better Academic Performance
3. CMHA Calls For Better Trained Police For Dealing With The Mentally Ill
4. Dealing With Nausea When Pregnant
5. Dealing with IBS
6. Starvation in pregnant women can cause heart disease to their children
7. Individuals with sleep related breathing disorders more prone to heart disease
8. And now they say infections can cause heart disease!!!!
9. And now they say infections can cause heart disease!!!!
10. Award for TTK Chitra heart valve prosthesis
11. Eat greens to have a ever green heart
Post Your Comments:
(Date:12/2/2008)...ire/ -- In response to the commentary entitled "Co...ory Infections, and the Vitamin D Deficiency Epide...upplement experts, Nordic Naturals announced today... compromise to consumers and actually offer health...al Vitamin A. According to Karin Yien, MD, Nordic ...
(Date:12/2/2008)...ollect and disseminate pharmacy experience and kno.... (PRWEB) December 2, 2008 -- Pharmacy OneSource,...ive to focus public and industry attention on med...f SPEAK will occur during the American Society of ...ical Meeting, to be held December 7-11 in Orlando,...
(Date:12/2/2008)...ealth, a leading provider of onsite health service... Balance, the athletic products company, has selec...ge onsite health clinics and to provide health ser...e , Burlington, VT (PRWEB...rovider of onsite employee health services and tec...
(Date:12/2/2008)...t of Normal Gait Deviations and Treatment Options ...s of a three-day workshop to be held at La Rabida ... Chicago, IL (PRWEB) December 2, 200...atment Options for the Child with Cerebral Palsy w...d at La Rabida Children,s Hospital Dec. 5 through ...
Breaking Medicine News(10 mins):Health News:Nordic Naturals Offers Cod Liver Oil Solutions in Response to Recent Vitamin A and Vitamin D Controversy 2Health News:Pharmacy OneSource Launches SPEAK Initiative to Promote Medication Safety Awareness 2Health News:Marathon Health Joins Forces with New Balance for Employee Health - Associate Health Services Provided at Three Maine Locations 2Health News:Marathon Health Joins Forces with New Balance for Employee Health - Associate Health Services Provided at Three Maine Locations 3Health News:La Rabida Children's Hospital to Host Three-Day Course on Gait Treatment Options for Children with Cerebral Palsy 2
...unday expressed concern at India's health indicato...as he urged the medical fraternity to revamp healt...den jubilee celebrations of the All India Institut... exhorted policy planners and doctors to emulate t...
...ersity Baptist Medical Center have begun a study p... steroids to prevent premature babies//. Premature... their lungs are not fully developed. Currently th...er synthetic steroids and to prolong the pregnancy...
...rganisation one in three women and one in seven m...at some point after the age of 50.The recommended ...8 and 50 years is 1000mg. Calcium, together with v...and helps in preventing brittle bone disease oste...
... contributor in the plant kingdom among pulses. Be... protein it is also known to have numerous other h...d, shown to lower cholesterol, slow the developmen...alth. Sometime back it was supposed to be extra b...
Other Medicine News:Health News:Medical Fraternity Urged To Revamp Indian Healthcare 2
(Date:12/1/2008)...ec. 1 GeoVax Labs, Inc.,...echnology company developing,human vaccines for d...rus) and,other infectious agents, announced today...ials will take place in twelve sites across North ...collaboration with The National Institutes of,Hea...
(Date:11/28/2008)...IS, Nov. 28 Eli Lilly an...mental New Drug Application (sNDA) from,the U.S. ... (duloxetine HCl),for the management of chronic p...he first half of 2009, adding data from a recently...is pain of the knee. , The decision does no...
(Date:11/25/2008)...areness can improve recovery , , Audio and ...ailable on the Mayo Clinic News Blog. Please see t..., ROCHESTER, Minn., Nov. 25 /PRNewswire-USNewsw...roke patients don,t think they,re having a stroke ...l their condition worsens. The findings appear in ...
(Date:11/25/2008)... Calif., Nov. 25 Pharmac...at the company has completed a Phase 1,clinical t...-class,small-molecule Factor VIIa inhibitor. The ...teers to evaluate the safety and pharmacologic eff...27483 resulted in a linear dose,response in the I...
Breaking Medicine Technology:GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4FairWarning to Host Webinar Featuring HIMSS Chairman and Healthcare Executive from PricewaterhouseCoopers on Electronic Health Record Privacy and Comp 11766 1FairWarning to Host Webinar Featuring HIMSS Chairman and Healthcare Executive from PricewaterhouseCoopers on Electronic Health Record Privacy and Comp 11766 2The Brand Experience Teams With World Vision to Launch Experience 3A AIDS Multi Media Exhibit 11763 1The Brand Experience Teams With World Vision to Launch Experience 3A AIDS Multi Media Exhibit 11763 2The Brand Experience Teams With World Vision to Launch Experience 3A AIDS Multi Media Exhibit 11763 3Bioniche Provides Update on Refractory Bladder Cancer Trial with Urocidin 28TM 29 11760 1Bioniche Provides Update on Refractory Bladder Cancer Trial with Urocidin 28TM 29 11760 2Bioniche Provides Update on Refractory Bladder Cancer Trial with Urocidin 28TM 29 11760 3AAFPRS Speaks to the Safety of BOTOX 28R 29 Cosmetic 11759 1AAFPRS Speaks to the Safety of BOTOX 28R 29 Cosmetic 11759 2
...geting Pro-Inflammatory,Protein -, GAITHERSBURG, M...mune, Inc. today announced the publication of prec...obility group box,protein-1 (HMGB1), a nuclear DNA...oimmune diseases such as systemic lupus,erythemato...to be,published in the May 2007 issue of Nature Im...
...wire-FirstCall/ --,VioQuest Pharmaceuticals, Inc. ...used on acquiring, developing and,commercializing ...,preclinical studies of VQD- 002, a direct inhibit...d hematologic tumors.,Pre-clinical data was presen...f the American Association for Cancer Research,(AA...
Other Medicine Technology:MedImmune Publishes New Data in Nature Immunology Demonstrating The,Role HMGB1 May Play in Systemic Autoimmune Diseases 2MedImmune Publishes New Data in Nature Immunology Demonstrating The,Role HMGB1 May Play in Systemic Autoimmune Diseases 3VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 2VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 3VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 4VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 5
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
Medicine Products: